<DOC>
	<DOCNO>NCT02076750</DOCNO>
	<brief_summary>The purpose study determine whether weekly dose oral vitamin D3 effective correcting low vitamin D level child adolescent inflammatory bowel disease ( also know Crohn 's disease ulcerative colitis ) .</brief_summary>
	<brief_title>Weekly Vitamin D Pediatric IBD</brief_title>
	<detailed_description>The role vitamin D skeletal health well establish . More recently , vitamin D implicate multiple disease state currently topic much discussion pediatric adult medical literature . Individuals gastrointestinal hepatobiliary disease limit absorption dietary vitamin D individual limit sunlight exposure darker skin color risk suboptimal vitamin D status . Recent joint guideline North American European Societies Pediatric Gastroenterology , Hepatology Nutrition ( NASPGHAN ESPGHAN , respectively ) recommend routine surveillance treatment vitamin D insufficiency/deficiency child affect inflammatory bowel disease ( IBD ) , namely Crohn 's disease ( CD ) ulcerative colitis ( UC ) . Current recommendation prolong daily dose oral vitamin D , study child chronic disease demonstrate benefit improve compliance less frequent , high dose vitamin D. The primary goal pilot study establish whether weekly dose vitamin D correct suboptimal vitamin D status child inflammatory bowel disease . A secondary goal evaluate whether pediatric IBD patient darker skin respond differently vitamin D therapy lighter-skinned counterpart .</detailed_description>
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>Inflammatory Bowel Diseases</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>1 . Established diagnosis inflammatory bowel disease make pediatric gastroenterologist confirm histopathology 2 . Serum 25OH vitamin D level &lt; 30 ng/mL time enrollment . 3 . Age 821 year 4 . Weight &gt; 20 kg 5 . Parent , guardian , subject ( applicable ) able give consent/assent 1 . Inability ingest oral vitamin D3 capsule 2 . Presence known hepatobiliary disease 3 . Presence known kidney disease history renal stone 4 . Use systemic steroid within 60 day prior enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Inflammatory Bowel Diseases</keyword>
	<keyword>Vitamin D</keyword>
	<keyword>Cholecalciferol</keyword>
	<keyword>Skin Pigmentation</keyword>
</DOC>